StockData
ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc. (ADRX) stock

ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$13.82−0.18 (-1.29%)

Close on Nov 17, 2026Market cap $1.48BP/E –Yield –

ADARx Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for ADARx Pharmaceuticals

ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ADARx Pharmaceuticals figures

See a number that looks wrong?